ROPIN HEAVY 0.75%

ROPIN HEAVY 0.75% About

 BRAND NAME: ROPIN HEAVY 0.75% 4ML AMP
 GENERIC / SALT: Ropivacaine Hydrochloride Injection I.P.
 FORM & STRENGTH: Injectable Solution, 0.75% w/v (7.5mg/mL)  4mL Ampoule
 COMPANY / MANUFACTURER: Neon Laboratories Ltd

Ropin Heavy 0.75% 4mL Injection is a longacting local anaesthetic formulation containing Ropivacaine Hydrochloride, used by healthcare professionals to produce regional or local anaesthesia during surgical procedures and to manage pain. It works by temporarily blocking the transmission of pain signals in nerves, helping to numb targeted areas of the body.

         Surgical Anaesthesia: Provides effective anaesthesia during surgical interventions, including orthopaedic or obstetric procedures.

         Local/Regional Pain Management: Used for local surgical blocks, epidural infusions, or nerve blocks to control intraoperative and postoperative pain.

Ropivacaine is a longacting amidetype local anaesthetic that acts by blocking sodium ion influx in nerve membranes, inhibiting the initiation and conduction of nerve impulses. This results in temporary loss of sensation (numbness) in the injected area.

         Route: Administered parenterally (injection) by a trained anaesthesiologist or healthcare professional.

         Settings: Only in clinical environments (e.g., operating rooms, pain clinics).

         Dosage and injection technique depend on clinical indication, nerve block type, and patient status.

Longacting local anaesthetic with both anaesthetic and analgesic properties.
Suitable for regional blocks, epidural anaesthesia, and surgical analgesia.
Provides effective pain relief and sensory blockade with reduced motor blockade.
Good safety profile when used under professional supervision.

         For use only by qualified healthcare professionals experienced in local anaesthesia.

         Contraindications: Known hypersensitivity to ropivacaine or other amide local anaesthetics.

         Monitor patients for cardiovascular and central nervous system effects; inadvertent intravascular injection can lead to serious complications.

         Use caution in patients with hepatic impairment or severe systemic disease.